Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

PEHA.JK Logo

PEHA.JK - Current Price

$306.00

Company Information

▼
Company Name
Phapros Tbk PT
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
JK
ISIN: ID1000147507
Currency: IDR
Full Time Employees: 1,264
Phone: 62 21 576 2709
Website: https://www.phapros.co.id
Fiscal Year End: December
Description:

PT Phapros Tbk, together with its subsidiaries, operates in the pharmaceutical industry in Indonesia. The company operates through Ethical; Over the Counter (OTC) Drugs; Generic Drugs Bearing (OCB); and Toll-in segments. It offers OTC drugs, including Antimo Anak, Antimo tablet, Livron B Plex, X-Gra, Becefort Sirop and tablet, Noza, Febrinex, Betafort suspensi, and Hemorogard. The company also provides ethical generic and branded products; and medical devices, as well as toll manufacturing. It also exports its products. The company was founded in 1954 and is headquartered in Jakarta Selatan, Indonesia. PT Phapros Tbk is a subsidiary of PT Kimia Farma Tbk.

Address:

Menara Rajawali Lantai 17, Jakarta Selatan, Indonesia, 12950

Directors & Officers

▼
Name Title Year Born
Mr. Yudhi Rangkuti Finance, Risk Management & Human Capital Director and Director NA
Mr. Erfan Rio Prananto General Manager of Accounting NA
Mr. Maraja Jeson Siregar Director of Marketing & Director NA
Mr. Riza Effendi Head of Internal Control Unit 1969
Mr. Diah Istantri Head of Risk Management Department NA
Ms. Zahmilia Akbar Corporate Secretary 1988

Shares Statistics

▼
Shares Outstanding: 840.00M
Shares Float: 275.27M
% Insiders: 7,306.50%
% Institutions: 0.00%

Valuation Metrics

▼
Enterprise Value: $887.39B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $255.36B
EBITDA: $-127.94B
Book Value: $463.99
Earnings/Share: $-249.01
Profit Margin: -24.48%
Operating Margin: 4.27%
ROA (TTM): -6.67%
ROE (TTM): -38.66%
Revenue (TTM): $856.09B
Revenue/Share (TTM): $1.02K
Earnings Growth (YOY): 92.90%
Revenue Growth (YOY): 10.30%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Jun 30, 2023 3.61 N/A N/A N/A
Mar 31, 2023 5.61 N/A N/A N/A
Dec 31, 2022 13.04 N/A N/A N/A
Sep 30, 2022 7.12 N/A N/A N/A
Jun 30, 2022 6.59 N/A N/A N/A
Mar 31, 2022 6.67 N/A N/A N/A
Dec 31, 2021 0.23 N/A N/A N/A
Sep 30, 2021 0.55 N/A N/A N/A
Jun 30, 2021 3.89 N/A N/A N/A
Mar 31, 2021 8.52 N/A N/A N/A
Dec 31, 2020 -1.81 N/A N/A N/A
Sep 30, 2020 27.54 N/A N/A N/A
Jun 30, 2020 48.47 N/A N/A N/A
Mar 31, 2020 -16.47 N/A N/A N/A
Dec 31, 2019 50.05 N/A N/A N/A
Sep 30, 2019 14.57 N/A N/A N/A
Jun 30, 2019 50.79 N/A N/A N/A
Mar 31, 2019 6.05 N/A N/A N/A

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $92.00B $N/A $1,430.04B $1,036.92B $379.75B
2023-12-31 $65.84B $N/A $1,765.89B $995.56B $749.53B
2022-12-31 $147.68B $N/A $1,806.28B $1,034.46B $751.05B
2021-12-31 $94.35B $N/A $1,838.54B $1,097.56B $719.49B
2020-12-31 $60.19B $N/A $1,915.99B $1,175.08B $719.65B
2019-12-31 $106.57B $N/A $2,096.72B $1,275.11B $800.51B
2018-12-31 $108.63B $N/A $1,868.66B $1,078.87B $769.93B
2017-12-31 $147.05B $N/A $1,175.94B $474.55B $701.39B
2016-12-31 $70.89B $N/A $883.29B $261.21B $622.08B
2015-12-31 $55.52B $N/A $680.65B $230.93B $449.72B
2014-12-31 $38.82B $N/A $638.09B $229.84B $408.25B
2013-12-31 $27.52B $N/A $643.09B $251.69B $382.97B
2012-12-31 $43.63B $N/A $558.64B $183.02B $367.24B
2011-12-31 $20.54B $N/A $462.59B $123.42B $339.17B

Watchlist

0

No stocks in watchlist